{"id":470727,"date":"2021-04-05T08:04:30","date_gmt":"2021-04-05T12:04:30","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=470727"},"modified":"2021-04-05T08:04:30","modified_gmt":"2021-04-05T12:04:30","slug":"blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\/","title":{"rendered":"Blueprint Medicines to Host Virtual Investor Event and Webcast to Review New Data Presented at AACR Annual Meeting on Monday, April 12, 2021"},"content":{"rendered":"
\n

— Presentations showcase the company’s scientific leadership in precision oncology and hematology —<\/h2>\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n CAMBRIDGE, Mass.<\/span>, April 5, 2021<\/span> \/PRNewswire\/ —\u00a0Blueprint Medicines Corporation (NASDAQ: BPMC), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, April 12, 2021<\/span> to review new data for multiple research- and clinical-stage programs across its precision oncology and hematology portfolio. The data will also be presented at the American Association for Cancer Research (AACR) Annual Meeting 2021, April 9-14, 2021<\/span>.<\/p>\n

\n

\n
\n \"Print\"
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n Conference Call Information<\/b>\n <\/p>\n

To access the live call, please dial\u00a0(855) 728-4793 (domestic) or (503) 343-6666 (international) and refer to conference ID 5548976. A webcast of the conference call will be available in the Investors & Media section of\u00a0Blueprint Medicines’\u00a0website at\u00a0http:\/\/ir.blueprintmedicines.com<\/a>. The archived webcast will be available on\u00a0Blueprint Medicines’\u00a0website approximately two hours after the conference call and will be available for 30 days following the call.<\/p>\n

\n About Blueprint Medicines <\/b>\n <\/p>\n

Blueprint Medicines is a global precision therapy company that invents life-changing therapies for people with cancer and hematologic disorders. Applying an approach that is both precise and agile, we create medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease. Since 2011, we have leveraged our research platform, including expertise in molecular targeting and world-class drug design capabilities, to rapidly and reproducibly translate science into a broad pipeline of precision therapies. Today, we are delivering approved medicines directly to patients in the United States<\/span> and Europe<\/span>, and we are globally advancing multiple programs for genomically defined cancers, systemic mastocytosis, and cancer immunotherapy. For more information, visit www.BlueprintMedicines.com<\/a>\u00a0and follow us on Twitter<\/a>\u00a0(@BlueprintMeds) and\u00a0LinkedIn<\/a>.<\/p>\n

\u00a0<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021-301261789.html<\/a><\/p>\n

SOURCE Blueprint Medicines Corporation<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

— Presentations showcase the company’s scientific leadership in precision oncology and hematology — PR Newswire CAMBRIDGE, Mass., April 5, 2021 \/PRNewswire\/ —\u00a0Blueprint Medicines Corporation (NASDAQ: BPMC), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, April 12, 2021 to review new data for multiple research- and clinical-stage programs across its precision oncology and hematology portfolio. The data will also be presented at the American Association for Cancer Research (AACR) Annual Meeting 2021, April 9-14, 2021. Conference Call Information To access the live call, please dial\u00a0(855) 728-4793 (domestic) or (503) 343-6666 (international) and refer to conference ID 5548976. A webcast of the conference call will be available in the Investors & Media … <\/p>\n

Continue reading “Blueprint Medicines to Host Virtual Investor Event and Webcast to Review New Data Presented at AACR Annual Meeting on Monday, April 12, 2021”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-470727","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBlueprint Medicines to Host Virtual Investor Event and Webcast to Review New Data Presented at AACR Annual Meeting on Monday, April 12, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Blueprint Medicines to Host Virtual Investor Event and Webcast to Review New Data Presented at AACR Annual Meeting on Monday, April 12, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"— Presentations showcase the company’s scientific leadership in precision oncology and hematology — PR Newswire CAMBRIDGE, Mass., April 5, 2021 \/PRNewswire\/ —\u00a0Blueprint Medicines Corporation (NASDAQ: BPMC), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, April 12, 2021 to review new data for multiple research- and clinical-stage programs across its precision oncology and hematology portfolio. The data will also be presented at the American Association for Cancer Research (AACR) Annual Meeting 2021, April 9-14, 2021. Conference Call Information To access the live call, please dial\u00a0(855) 728-4793 (domestic) or (503) 343-6666 (international) and refer to conference ID 5548976. A webcast of the conference call will be available in the Investors & Media … Continue reading "Blueprint Medicines to Host Virtual Investor Event and Webcast to Review New Data Presented at AACR Annual Meeting on Monday, April 12, 2021"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-05T12:04:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/221118\/blueprint_medicines_logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Blueprint Medicines to Host Virtual Investor Event and Webcast to Review New Data Presented at AACR Annual Meeting on Monday, April 12, 2021\",\"datePublished\":\"2021-04-05T12:04:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\\\/\"},\"wordCount\":316,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/221118\\\/blueprint_medicines_logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\\\/\",\"name\":\"Blueprint Medicines to Host Virtual Investor Event and Webcast to Review New Data Presented at AACR Annual Meeting on Monday, April 12, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/221118\\\/blueprint_medicines_logo.jpg\",\"datePublished\":\"2021-04-05T12:04:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/221118\\\/blueprint_medicines_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/221118\\\/blueprint_medicines_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Blueprint Medicines to Host Virtual Investor Event and Webcast to Review New Data Presented at AACR Annual Meeting on Monday, April 12, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Blueprint Medicines to Host Virtual Investor Event and Webcast to Review New Data Presented at AACR Annual Meeting on Monday, April 12, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\/","og_locale":"en_US","og_type":"article","og_title":"Blueprint Medicines to Host Virtual Investor Event and Webcast to Review New Data Presented at AACR Annual Meeting on Monday, April 12, 2021 - Market Newsdesk","og_description":"— Presentations showcase the company’s scientific leadership in precision oncology and hematology — PR Newswire CAMBRIDGE, Mass., April 5, 2021 \/PRNewswire\/ —\u00a0Blueprint Medicines Corporation (NASDAQ: BPMC), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, April 12, 2021 to review new data for multiple research- and clinical-stage programs across its precision oncology and hematology portfolio. The data will also be presented at the American Association for Cancer Research (AACR) Annual Meeting 2021, April 9-14, 2021. Conference Call Information To access the live call, please dial\u00a0(855) 728-4793 (domestic) or (503) 343-6666 (international) and refer to conference ID 5548976. A webcast of the conference call will be available in the Investors & Media … Continue reading \"Blueprint Medicines to Host Virtual Investor Event and Webcast to Review New Data Presented at AACR Annual Meeting on Monday, April 12, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-05T12:04:30+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/221118\/blueprint_medicines_logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Blueprint Medicines to Host Virtual Investor Event and Webcast to Review New Data Presented at AACR Annual Meeting on Monday, April 12, 2021","datePublished":"2021-04-05T12:04:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\/"},"wordCount":316,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/221118\/blueprint_medicines_logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\/","name":"Blueprint Medicines to Host Virtual Investor Event and Webcast to Review New Data Presented at AACR Annual Meeting on Monday, April 12, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/221118\/blueprint_medicines_logo.jpg","datePublished":"2021-04-05T12:04:30+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/221118\/blueprint_medicines_logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/221118\/blueprint_medicines_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-host-virtual-investor-event-and-webcast-to-review-new-data-presented-at-aacr-annual-meeting-on-monday-april-12-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Blueprint Medicines to Host Virtual Investor Event and Webcast to Review New Data Presented at AACR Annual Meeting on Monday, April 12, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/470727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=470727"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/470727\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=470727"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=470727"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=470727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}